Rare diseases
Investigational molecules
Locations
Back to France649 clinical trials in Pierre Benite, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease
FranceStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
FranceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
FranceStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis
FranceStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
FranceStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
FranceStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
FranceStudy on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis
FranceStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
FranceStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
FranceWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on vaccine development against major viral infections. Studies include evaluations of new treatments for influenza, cytomegalovirus, and yellow fever.
Research aims to enhance prevention and protection against these significant viral threats.
Groundbreaking research in inflammatory bowel diseases, exploring innovative therapeutic approaches including fecal microbiota transplantation for both Crohn's disease and ulcerative colitis.
Studies focus on developing alternative treatment strategies for patients with limited therapeutic options.
Comprehensive research into blood cancers and solid tumors, including multiple myeloma, leukemia, and advanced prostate cancer. Trials evaluate novel therapeutic combinations and targeted treatments.
Focus on developing more effective and personalized treatment approaches.
Studies addressing heart failure prevention, chronic kidney disease, and metabolic disorders. Research includes evaluation of novel drug combinations and therapeutic strategies.
Emphasis on preventing disease progression and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
